XENE (Xenon Pharmaceuticals) Common Stock: $2,421.83 Mil (As of Mar. 2026)


XENE Xenon Pharmaceuticals Inc XENE
25 GF Score
Price $60.92
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals Common Stock?

Xenon Pharmaceuticals XENE +1.09% 25 Common Stock is $2,421.83 Mil as of Mar. 2026. GuruFocus rates XENE with a GF Score™ of 25/100. The stock has 5 warning signs investors should review.

Xenon Pharmaceuticals's quarterly common stock increased from Sep. 2025 ($1,475.37 Mil) to Dec. 2025 ($1,598.57 Mil) and increased from Dec. 2025 ($1,598.57 Mil) to Mar. 2026 ($2,421.83 Mil).

Xenon Pharmaceuticals's annual common stock increased from Dec. 2023 ($1,436.37 Mil) to Dec. 2024 ($1,456.84 Mil) and increased from Dec. 2024 ($1,456.84 Mil) to Dec. 2025 ($1,598.57 Mil).

Xenon Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Xenon Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals Common Stock Chart

Xenon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 783.17 1,065.14 1,436.37 1,456.84 1,598.57

Xenon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,460.85 1,469.20 1,475.37 1,598.57 2,421.83
XENE
25GF Score
Xenon Pharmaceuticals Inc XENE
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xenon Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $2,421.83 Mil mean?
Xenon Pharmaceuticals (XENE) has a Common Stock of $2,421.83 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Xenon Pharmaceuticals and its competitors.
Is Xenon Pharmaceuticals' Common Stock too high?
Xenon Pharmaceuticals' current Common Stock is $2,421.83 Mil. Overall, Xenon Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Xenon Pharmaceuticals' Common Stock compare to DFTX and LEGN?
Xenon Pharmaceuticals' Common Stock of $2,421.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Xenon Pharmaceuticals and its competitors. Xenon Pharmaceuticals's current Common Stock is $2,421.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xenon Pharmaceuticals stock overvalued right now?
Xenon Pharmaceuticals (XENE) has a current Common Stock of $2,421.83 Mil. The current Common Stock is $2,421.83 Mil. Xenon Pharmaceuticals' overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Xenon Pharmaceuticals (XENE), the current Common Stock is $2,421.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xenon Pharmaceuticals Business Description

Other Exchanges XP0:Germany
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
25GF Score

Get the complete analysis for XENE

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$60.92
Price